|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
11283289X |
| 003 |
DE-627 |
| 005 |
20230427004426.0 |
| 007 |
tu |
| 008 |
921122s1992 xxu||||| 00| ||eng c |
| 020 |
|
|
|a 0881678309
|c hardcover
|9 0-88167-830-9
|
| 035 |
|
|
|a (DE-627)11283289X
|
| 035 |
|
|
|a (DE-576)037096869
|
| 035 |
|
|
|a (DE-599)GBV11283289X
|
| 035 |
|
|
|a (OCoLC)24285336
|
| 035 |
|
|
|a (DE-604)8066297885
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XD-US
|
| 050 |
|
0 |
|a RC582.17
|
| 060 |
|
0 |
|a QV 600 C6384
|
| 082 |
0 |
|
|a 616.97/071
|
| 084 |
|
|
|a XG 4400
|2 rvk
|0 (DE-625)rvk/152802:12905
|
| 084 |
|
|
|a XI 2091
|2 rvk
|0 (DE-625)rvk/152980:13000
|
| 084 |
|
|
|a XI 6600
|2 rvk
|0 (DE-625)rvk/153022:12905
|
| 245 |
1 |
0 |
|a Clinical immunotoxicology
|c ed.-in-chief David S. Newcombe. Eds : Noel R. Rose ...
|
| 264 |
|
1 |
|a New York, NY
|b Raven Press
|c 1992
|
| 300 |
|
|
|a XII, 450 S.
|b Ill., graph. Darst.
|c 24 cm
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Includes bibliographical references and index
|
| 653 |
|
0 |
|a Immunotoxicology
|
| 653 |
|
0 |
|a Drugs
|a toxicity
|
| 653 |
|
0 |
|a Immunity
|a drug effects
|
| 653 |
|
0 |
|a Immunologic
|a chemically induced
|
| 653 |
|
0 |
|a Xenobiotics
|a metabolism
|
| 655 |
|
7 |
|a Aufsatzsammlung
|0 (DE-588)4143413-4
|0 (DE-627)105605727
|0 (DE-576)209726091
|2 gnd-content
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4045687-0
|0 (DE-627)104791454
|0 (DE-576)209066377
|a Pharmakologie
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4193155-5
|0 (DE-627)105229180
|0 (DE-576)210085444
|a Xenobiotikum
|2 gnd
|
| 689 |
0 |
|
|5 (DE-627)
|
| 700 |
1 |
|
|a Newcombe, David S.
|d 1929-
|e hrsg
|0 (DE-588)114585950X
|0 (DE-627)1005750386
|0 (DE-576)171652592
|4 edt
|
| 700 |
1 |
|
|a Rose, Noel R.
|4 oth
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a ISIL_DE-27
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_62
|
| 912 |
|
|
|a ISIL_DE-28
|
| 912 |
|
|
|a GBV_ILN_65
|
| 912 |
|
|
|a ISIL_DE-3
|
| 912 |
|
|
|a GBV_ILN_65_a015
|
| 912 |
|
|
|a GBV_ILN_101
|
| 912 |
|
|
|a ISIL_DE-Ma14
|
| 912 |
|
|
|a GBV_ILN_252
|
| 912 |
|
|
|a GBV_ILN_252_i130
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a ISIL_DE-15-292
|
| 935 |
|
|
|i Blocktest
|
| 936 |
r |
v |
|a XG 4400
|b Allgemeines
|k Medizin
|k Pathologie
|k Allgemeine Pathologie und pathologische Anatomie
|k Pathologie der Reaktionen (Fieber)
|k Immunität, Immunpathologie (Autoaggressionskrankheit)
|k Allgemeines
|0 (DE-627)1271493985
|0 (DE-625)rvk/152802:12905
|0 (DE-576)201493985
|
| 936 |
r |
v |
|a XI 2091
|b Innere Medizin, Infektionskrankheiten
|k Medizin
|k Pharmakologie und Toxikologie
|k Allgemeine Pharmakologie
|k Arzneimittelnebenwirkung, iatrogene Krankheit
|k B. Sachschlüssel
|k Unterteilung nach medizinischen Disziplinen
|k Innere Medizin, Infektionskrankheiten
|0 (DE-627)1277039798
|0 (DE-625)rvk/152980:13000
|0 (DE-576)207039798
|
| 936 |
r |
v |
|a XI 6600
|b Allgemeines
|k Medizin
|k Pharmakologie und Toxikologie
|k Spezielle Pharmakologie und Toxikologie
|k Immunsuppressiva
|k Allgemeines
|0 (DE-627)1271551748
|0 (DE-625)rvk/153022:12905
|0 (DE-576)201551748
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 616.97/071
|
| 980 |
|
|
|2 31
|1 01
|x 0027
|b 220865698
|c 00
|f Mag3
|d Mag3 A 9399
|e u
|j --%%--
|c 09
|f --%%--
|d 96 NA 11848/1
|e --%%--
|j --%%--
|y n
|z 01-01-96
|
| 980 |
|
|
|2 62
|1 01
|x 0028
|b 093789718
|c 00
|f 28/BB4
|d XG 4420 N537
|e u
|j --%%--
|c 09
|f --%%--
|d 93 A 13829
|e --%%--
|j --%%--
|y zbb4
|z 03-06-94
|
| 980 |
|
|
|2 62
|1 02
|x 0028
|b 779108744
|c 00
|f 28/BB4
|d XG 4420 N537
|e u
|j --%%--
|y zbb4
|z 28-09-06
|
| 980 |
|
|
|2 65
|1 01
|x 3/4
|b 106095358
|c 00
|f Ha 4
|d XG 4400 101
|e u
|j --%%--
|c 09
|f Ha 4
|d PA Phakol 203
|e --%%--
|j --%%--
|y ra015
|z 14-05-07
|
| 980 |
|
|
|2 101
|1 01
|x 3101
|b 383504767
|c 00
|f IMMB
|d Mibi-0311-059
|e s
|j --%%--
|y r
|z 21-03-00
|
| 980 |
|
|
|2 252
|1 01
|x 4252/130
|b 723524211
|c 00
|f Ka51
|d G 442
|e s
|j --%%--
|y zi130
|z 06-06-05
|
| 980 |
|
|
|2 2010
|1 01
|x DE-15-292
|b 3221961596
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|y l01
|z 21-06-96
|
| 982 |
|
|
|2 31
|1 00
|x DE-27
|8 00
|a Pharmakologie / Xenobiotikum
|
| 982 |
|
|
|2 252
|1 01
|x 4252/130
|8 00
|a Immunologie
|
| 982 |
|
|
|2 252
|1 01
|x 4252/130
|8 01
|a Immunotoxin
|
| 983 |
|
|
|2 31
|1 00
|x DE-27
|8 00
|a MED:IB:300
|
| 983 |
|
|
|2 101
|1 00
|x DE-Ma14
|8 00
|a 0311.11
|
| 983 |
|
|
|2 101
|1 00
|x DE-Ma14
|8 01
|a 0601.06
|
| 983 |
|
|
|2 252
|1 01
|x 4252/130
|8 00
|a GD
|
| 984 |
|
|
|2 31
|1 01
|x 0027
|a 027$013698346
|
| 984 |
|
|
|2 62
|1 01
|x 0028
|a 28$007708882
|
| 984 |
|
|
|2 62
|1 02
|x 0028
|a 28$010521879
|
| 984 |
|
|
|2 65
|1 01
|x 3/4
|a 3/15$000399884
|
| 985 |
|
|
|2 31
|1 01
|x 0027
|a C96/R/241
|
| 985 |
|
|
|2 62
|1 01
|x 0028
|a 28/039 1994.96
|
| 985 |
|
|
|2 62
|1 02
|x 0028
|a 28/039 1/92
|
| 985 |
|
|
|2 65
|1 01
|x 3/4
|a 17/231/93
|
| 985 |
|
|
|2 252
|1 01
|x 4252/130
|a 1992/0125
|
